Episode Details

Utah’s new AI chatbot, Doctronic, is revolutionizing prescription refills—letting patients skip the doctor’s office for certain meds—but it’s sparking a firestorm over whether AI is ready to handle tasks once reserved for licensed physicians. Operating under a state “regulatory sandbox,” the system is currently overseen by AI experts and human doctors, but plans to go fully automated soon. The medical licensing board was blindsided by its launch, raising alarms about safety, especially for high-risk drugs like blood thinners. Doctors warn that patient conditions evolve, and automated refills could be dangerous without real-time human oversight. While other states like Texas and Wyoming are following suit, and lawmakers push for formal AI licensing, the FDA remains hands-off—though safety remains paramount. This fast-moving experiment could save time now, but experts fear rushing ahead without public trust could backfire.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/bc542b2140abe3ed